Cargando…

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course

OBJECTIVE: To determine if altered tryptophan (Trp) metabolism is associated with MS risk or disease severity in children. METHODS: Participants with pediatric‐onset MS and clinically isolated syndrome (CIS) within 4 years of disease onset and healthy controls underwent collection of serum. Longitud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nourbakhsh, Bardia, Bhargava, Pavan, Tremlett, Helen, Hart, Janace, Graves, Jennifer, Waubant, Emmanuelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186945/ https://www.ncbi.nlm.nih.gov/pubmed/30349856 http://dx.doi.org/10.1002/acn3.637

Ejemplares similares

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls
por: Tremlett, Helen, et al.
Publicado: (2016)

Biosensor vital sign detects multiple sclerosis progression
por: Krysko, Kristen M., et al.
Publicado: (2020)

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
por: Fitzgerald, Kathryn C., et al.
Publicado: (2021)

The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
por: Tremlett, Helen, et al.
Publicado: (2021)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Gut microbiome is associated with multiple sclerosis activity in children
por: Horton, Mary K., et al.
Publicado: (2021)

Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases
por: Liang, Geoffrey, et al.
Publicado: (2022)

Several household chemical exposures are associated with pediatric‐onset multiple sclerosis
por: Mar, Soe, et al.
Publicado: (2018)

miRNA contributions to pediatric‐onset multiple sclerosis inferred from GWAS
por: Rhead, Brooke, et al.
Publicado: (2019)

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006)

Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis
por: Greenberg, Benjamin M., et al.
Publicado: (2021)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
por: Mandel, Leslie A, et al.
Publicado: (2021)

Urban air quality and associations with pediatric multiple sclerosis
por: Lavery, Amy M., et al.
Publicado: (2018)

The Multiple Sclerosis Prodrome: Evidence to Action
por: Tremlett, Helen, et al.
Publicado: (2022)

The effect of smoking on the symptoms and progression of multiple sclerosis: a review
por: Shirani, Afsaneh, et al.
Publicado: (2010)

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis
por: Gaetani, Lorenzo, et al.
Publicado: (2020)

Heterogeneity in association of remote herpesvirus infections and pediatric MS
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

Is multiple sclerosis a risk factor for infections?
por: Lechner-Scott, Jeannette, et al.
Publicado: (2020)

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
por: Castillo-Trivino, Tamara, et al.
Publicado: (2013)

The Role of Remote Monitoring in Evaluating Fatigue in Multiple Sclerosis: A Review
por: Block, Valerie J., et al.
Publicado: (2022)

Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease
por: Sacco, Simone, et al.
Publicado: (2023)

Altered Levels of Toll-Like Receptors in Circulating Extracellular Vesicles in Multiple Sclerosis
por: Bhargava, Pavan, et al.
Publicado: (2019)

The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No
por: Tremlett, Helen, et al.
Publicado: (2021)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Polypharmacy and multiple sclerosis: A population-based study
por: Chertcoff, Anibal, et al.
Publicado: (2022)

Defining the clinical course of multiple sclerosis: The 2013 revisions
por: Lublin, Fred D., et al.
Publicado: (2014)

Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
por: Lovelace, Michael D., et al.
Publicado: (2016)

COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
por: Fitzgerald, Kathryn C., et al.
Publicado: (2022)

Using an animal model to predict the effective human dose for oral multiple sclerosis drugs
por: Liu, Wei, et al.
Publicado: (2022)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis
por: Cha, Lilian, et al.
Publicado: (2018)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
por: Safavi, Farinaz, et al.
Publicado: (2020)

Neonatal and Delivery Outcomes in Women with Multiple Sclerosis
por: van der Kop, Mia L, et al.
Publicado: (2011)

Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis
por: Salama, Sara, et al.
Publicado: (2020)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review
por: McKay, Kyla A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hl5vkil43sa02r25dfqcdv7p0t